Clinical trial
MOLECULAR BIOMARKERS IN DELIRIUM AND DEMENTIA
NCT05060614 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MOLECULAR BIOMARKERS IN DELIRIUM AND DEMENTIA
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2016
- Completion date
- December 30, 2027
- Enrollment
- 700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.